News for Molecular Diagnostics

Eight BRC projects get RCF funding

7 September 2020 · Listed under Cardiovascular, Clinical Informatics and Big Data, Diabetes and Metabolism, Gastroenterology and Mucosal Immunity, Genomic Medicine, Haematology and Stem Cells, Imaging, Molecular Diagnostics, Multi-Modal Cancer Therapies, Multimorbidity and Long-Term Conditions, Neurological Conditions, Stroke and Vascular Dementia, Surgical Innovation and Evaluation, Technology and Digital Health

Eight Oxford BRC proposals, many covering a number of themes, have been awarded NIHR Research Capability Funding (RCF) funding to take forward key areas of research. The selected projects that will be supported include: Developing a research centre devoted to urgent and acute care The creation of a state-of-the-art imaging centre; and of a new … Read more

Test developed to identify new-borns at risk of leukaemia

21 August 2020 · Listed under Haematology and Stem Cells, Molecular Diagnostics

Oxford researchers have developed a new method to quickly identify cancerous cells in babies at risk of leukaemia. The team hope that the new protocol could make rapid testing more accessible for clinical laboratories around the globe. Until now, the only reliable way to know if a baby with Down’s syndrome is at risk of … Read more

BRC researchers’ work recognised with Vice-Chancellor’s Awards

30 July 2020 · Listed under Molecular Diagnostics, Surgical Innovation and Evaluation, Vaccines for Emerging and Endemic Diseases

A number of Oxford BRC-supported researchers have been recognised in this year’s University of Oxford Vice-Chancellor Innovation Awards. The Vice-Chancellor Innovation Awards celebrate research-led innovation that is having societal or economic impact. Prof Robert MacLaren, who leads the BRC’s Surgical Innovation theme, was named winner of the Inspiring Leadership category for his work on creation and spin-out of … Read more

Home colorectal cancer tests could prioritise patients for referral

20 July 2020 · Listed under Molecular Diagnostics, Multi-Modal Cancer Therapies

Non-invasive home-based tests that detect blood in patient stool samples offer an accurate and appropriate triaging method for GPs, according to University of Oxford researchers. The study, which is already informing a redesign of the colorectal cancer pathway at Oxford University Hospitals (OUH) NHS Foundation Trust, could prompt primary care services nationally to reprioritise symptomatic … Read more

Study discovers genetic changes linked to leukaemia in children with Down’s syndrome

11 July 2019 · Listed under Haematology and Stem Cells, Molecular Diagnostics

Researchers at the University of Oxford have discovered the specific gene mutations that are required for the development of leukaemia in children with Down’s syndrome. Children with Down’s syndrome have a 150-fold increased risk of myeloid leukaemia, and while some of the genetic causes of this have been previously established, this is the first study … Read more

Summary of the Crohn’s & Colitis Open Evening

23 April 2019 · Listed under Molecular Diagnostics

On Thursday 7th February 2019, over 170 members of the public affected by Crohn’s Disease or Ulcerative Colitis attended a ‘Crohn’s and Colitis Open Evening’ at the John Radcliffe Hospital, Oxford. Below is a PDF summary of the event plus a slideshow with slides from the Powerpoint presentation given at the Open Evening.

Oxford researchers develop new technique to analyse cancer cells’ life history

11 February 2019 · Listed under Haematology and Stem Cells, Molecular Diagnostics

A team of researchers from the University of Oxford has developed a new technique that allows scientists to reliably track genetic errors in individual cancer cells, and find out how these might lead to uncontrollable growth. The research by the MRC Weatherall Institute of Molecular Medicine, supported by the NIHR Oxford Biomedical Research Centre, could … Read more

MDS Patient Support Group learn more about treatment of condition

13 October 2017 · Listed under Haematology and Stem Cells, Molecular Diagnostics

Patients and relatives affected by Myelodysplastic Syndromes (MDS) have visited the MRC Weatherall Institute of Molecular Medicine (WIMM) at the John Radcliffe Hospital to find out more about advances in treating the condition. The members of the Oxford and Thames Valley MDS Patient Support Group visited the WIMM Friday 29 September. MDS are a group … Read more

OUR 20 RESEARCH THEMES